Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Research Article

Gastrointestinal Side Effects of Triple Immunosuppressive Therapy Evaluated by AC Biosusceptometry and Electrogastrography in Rats

Author(s): Denize J.R. Dallagnol, Luciana A. Corá, Loyane A. Gama, Romero S. Caló, José R.A. Miranda and Madileine F. Américo*

Volume 20, Issue 9, 2020

Page: [1494 - 1503] Pages: 10

DOI: 10.2174/1871530320666200505111456

Price: $65

Abstract

Background: Triple immunosuppressive therapy is associated with several gastrointestinal disorders. The aim of this study was to investigate the effects induced by the triple immunosuppressive therapy on the gastrointestinal tract of rats.

Methods: Male Wistar rats were randomly assigned into three experimental groups: Control: filtered water; TAC + MPS + PRED: treated with Tacrolimus plus Mycophenolate Sodium plus Prednisone; and CSA + AZA + PRED: treated with Cyclosporine plus Azathioprine plus Prednisone. The treatment was done for 14 days by gavage. Gastric emptying and contractility were evaluated by the Alternating Current Biosusceptometry (ACB) and Electrogastrography (EGG). Histological, biochemical and hematological analyses were also performed.

Results: Gastric emptying time was slower in the CSA + AZA + PRED group in comparison with control (p<0.01) and TAC + MPS + PRED groups (p<0.001). Animals treated with TAC + MPS + PRED showed accelerated gastric emptying (p<0.05) compared to control. The amplitude of gastric contractions in both immunosuppressed groups was higher than observed in the control. The frequency of gastric contractions for the CSA + AZA + PRED group was also increased (p<0.01). Results obtained by EGG were similar to those recorded with the ACB. The thickness of the circular layer from stomach muscle decreased in both immunosuppressed groups, while the longitudinal layer was reduced only in the CSA + AZA + PRED group.

Conclusion: Triple immunosuppressive therapy alters gastric motility, compromises the muscular layers and the association between CSA, AZA, and PRED provokes the major alterations in the structure and gastric function. Specific gastrointestinal side effects resulting from different immunosuppressive therapies still need to be elucidated in order to provide more effective and personalized therapy for patients.

Keywords: Alternating current biosusceptometry, immunotherapy, electrogastrography, gastrointestinal diseases, triple immunosuppressive therapy, stomach muscle.

« Previous Next »
Graphical Abstract

[1]
Spasovski, G.; Masin-Spasovska, J. How to improve the survival of the kidney transplant - is it only the pharmaceutical management? Expert Opin. Pharmacother., 2014, 15(7), 905-908.
[http://dx.doi.org/10.1517/14656566.2014.896900] [PMID: 24617949]
[2]
Lee, R.A.; Gabardi, S. Current trends in immunosuppressive therapies for renal transplant recipients. Am. J. Health Syst. Pharm., 2012, 69(22), 1961-1975.
[http://dx.doi.org/10.2146/ajhp110624] [PMID: 23135563]
[3]
Cossart, A.R.; Cottrell, W.N.; Campbell, S.B.; Isbel, N.M.; Staatz, C.E. Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patients. Transl. Androl. Urol., 2019, 8(Suppl. 2), S198-S213.
[http://dx.doi.org/10.21037/tau.2018.10.16] [PMID: 31236338]
[4]
Milone, M.C. Overview of the pharmacology and toxicology of immunosuppressant agents that require therapeutic drug monitoring. Personalized Immunosuppression in Transplantation; Elsevier, 2016, pp. 1-27.
[http://dx.doi.org/10.1016/B978-0-12-800885-0.00001-1]
[5]
Jolly, E.C. Watson, CJE Modern immunosuppression. Surg, 2011, 29, 312-318.
[6]
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group, “KDIGO clinical practice guideline for the care of kidney transplant recipients. Am. J. Transplant., 2009, 9, S1-S155.
[http://dx.doi.org/10.1111/j.1600-6143.2009.02834.x]
[7]
Brasil - Ministério da Saúde (BR) Portaria nº 712, de 13 de agosto de 2014 - protocolo Clínico e Diretrizes Terapêuticas: Imunossu ão no transplante renal;, Brasília (DF),. 2014. pp. 317-352
[8]
Sarkio, S.; Halme, L.; Kyllönen, L.; Salmela, K. Severe gastrointestinal complications after 1,515 adult kidney transplantations. Transpl. Int., 2004, 17(9), 505-510.
[http://dx.doi.org/10.1111/j.1432-2277.2004.tb00479.x] [PMID: 15517164]
[9]
Gautam, A. Gastrointestinal complications following transplantation. Surg. Clin. North Am., 2006, 86(5), 1195-1206. [vii.]
[http://dx.doi.org/10.1016/j.suc.2006.06.006] [PMID: 16962409]
[10]
Ekberg, H.; Tedesco-Silva, H.; Demirbas, A.; Vítko, S.; Nashan, B.; Gürkan, A.; Margreiter, R.; Hugo, C.; Grinyó, J.M.; Frei, U.; Vanrenterghem, Y.; Daloze, P.; Halloran, P.F. Reduced exposure to calcineurin inhibitors in renal transplantation. N. Engl. J. Med., 2007, 357(25), 2562-2575.
[http://dx.doi.org/10.1056/NEJMoa067411] [PMID: 18094377]
[11]
Ponticelli, C.; Colombo, D.; Novara, M.; Basilisco, G. Gastrointestinal symptoms impair quality of life in Italian renal transplant recipients but are under-recognized by physicians. Transpl. Int., 2010, 23(11), 1126-1134.
[http://dx.doi.org/10.1111/j.1432-2277.2010.01115.x] [PMID: 20525020]
[12]
Bunnapradist, S.; Neri, L.; Wong, W.; Lentine, K.L.; Burroughs, T.E.; Pinsky, B.W.; Takemoto, S.K.; Schnitzler, M.A. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am. J. Kidney Dis., 2008, 51(3), 478-486.
[http://dx.doi.org/10.1053/j.ajkd.2007.11.013] [PMID: 18295064]
[13]
Ponticelli, C.; Passerini, P. Gastrointestinal complications in renal transplant recipients. Transpl. Int., 2005, 18(6), 643-650.
[http://dx.doi.org/10.1111/j.1432-2277.2005.00134.x] [PMID: 15910287]
[14]
Lucan, V.C.; Berardinelli, L. Gastrointestinal side effects of post-transplant therapy. J. Gastrointestin. Liver Dis., 2016, 25(3), 367-373.
[http://dx.doi.org/10.15403/jgld.2014.1121.253.ptt] [PMID: 27689202]
[15]
Damasceno, D.C.; Sinzato, Y.K.; Bueno, A.; Netto, A.O.; Dallaqua, B.; Gallego, F.Q.; Iessi, I.L.; Corvino, S.B.; Serrano, R.G.; Marini, G.; Piculo, F.; Calderon, I.M.P.; Rudge, M.V.C. Mild diabetes models and their maternal-fetal repercussions. J. Diabetes Res., 2013, 2013473575
[http://dx.doi.org/10.1155/2013/473575] [PMID: 23878822]
[16]
Szarka, L.A.; Camilleri, M. Methods for measurement of gastric motility. Am. J. Physiol. Gastrointest. Liver Physiol., 2009, 296(3), G461-G475.
[http://dx.doi.org/10.1152/ajpgi.90467.2008] [PMID: 19147807]
[17]
Parkman, H.P.; Jones, M.P. Tests of gastric neuromuscular function. Gastroenterology, 2009, 136(5), 1526-1543.
[http://dx.doi.org/10.1053/j.gastro.2009.02.039] [PMID: 19293005]
[18]
Rao, S.S.C.; Camilleri, M.; Hasler, W.L.; Maurer, A.H.; Parkman, H.P.; Saad, R.; Scott, M.S.; Simren, M.; Soffer, E.; Szarka, L. Evaluation of gastrointestinal transit in clinical practice: Position paper of the American and European neurogastroenterology and motility societies. Neurogastroenterol. Motil., 2011, 23(1), 8-23.
[http://dx.doi.org/10.1111/j.1365-2982.2010.01612.x] [PMID: 21138500]
[19]
Rozov-Ung, I.; Mreyoud, A.; Moore, J.; Wilding, G.E.; Khawam, E.; Lackner, J.M.; Semler, J.R.; Sitrin, M.D. Detection of drug effects on gastric emptying and contractility using a wireless motility capsule. BMC Gastroenterol., 2014, 14, 2.
[http://dx.doi.org/10.1186/1471-230X-14-2] [PMID: 24383478]
[20]
Américo, M.F.; Marques, R.G.; Zandoná, E.A.; Andreis, U.; Stelzer, M.; Corá, L.A.; Oliveira, R.B.; Miranda, J.R.A. Validation of ACB in vitro and in vivo as a biomagnetic method for measuring stomach contraction. Neurogastroenterol. Motil, 2010.22, 1340- 1344-1344.e374.
[21]
Quini, C.C.; Américo, M.F.; Corá, L.A.; Calabresi, M.F.; Alvarez, M.; Oliveira, R.B.; Miranda, J.R.A. Employment of a noninvasive magnetic method for evaluation of gastrointestinal transit in rats. J. Biol. Eng., 2012, 6(1), 6.
[http://dx.doi.org/10.1186/1754-1611-6-6] [PMID: 22587220]
[22]
Dos Anjos-Ramos, L.; Gama, L.A.; Hauschildt, A.T.; Fujiwara, R.T.; Corá, L.A.; Américo, M.F. Electroacupuncture in rats infected with Strongyloides venezuelensis: Effects on gastrointestinal transit and parasitological measurements. Acupunct. Med., 2018, 36(1), 44-51.
[http://dx.doi.org/10.1136/acupmed-2016-011289] [PMID: 29102965]
[23]
Teixeira, M.C.B.; Magalhães, I.; Galvão, P.V.M.; Souza, G.S.; Miranda, J.R.A.; Oliveira, R.B.; Corá, L.A. Assessment of gastrointestinal motility in renal transplant recipients by alternate current biosusceptometry. Transplant. Proc., 2012, 44(8), 2384-2387.
[http://dx.doi.org/10.1016/j.transproceed.2012.07.048] [PMID: 23026600]
[24]
Teixeira, Mdo. C.; Américo, M.F.; Oliveira, R.B.; Miranda, J.R.A.; Romeiro, F.G.; Corá, L.A. Influence of post-transplant immunosuppressive therapy on gastrointestinal transit using biomagnetic method: a pilot study. Dig. Dis. Sci., 2015, 60(1), 174-180.
[http://dx.doi.org/10.1007/s10620-014-3335-8] [PMID: 25146844]
[25]
Corá, L.A.; Romeiro, F.G.; Stelzer, M.; Américo, M.F.; Oliveira, R.B.; Baffa, O.; Miranda, J.R.A. AC biosusceptometry in the study of drug delivery. Adv. Drug Deliv. Rev., 2005, 57(8), 1223-1241.
[http://dx.doi.org/10.1016/j.addr.2005.01.026] [PMID: 15935871]
[26]
Dall’Agnol, D.J.R.; Corá, L.A.; Teixeira, M.D.C.B.; de Lima, M.B.; Gama, L.A.; Miranda, J.R.A.; Américo, M.F. Gastrointestinal disorders after immunosuppression: An experimental model to evaluate the influence of monotherapy on motility parameters. Exp. Physiol., 2017, 102(8), 924-933.
[http://dx.doi.org/10.1113/EP086267] [PMID: 28556421]
[27]
Malinowski, M.; Martus, P.; Lock, J.F.; Neuhaus, P.; Stockmann, M. Systemic influence of immunosuppressive drugs on small and large bowel transport and barrier function. Transpl. Int., 2011, 24(2), 184-193.
[http://dx.doi.org/10.1111/j.1432-2277.2010.01167.x] [PMID: 21208295]
[28]
Bohra, R.; Schöning, W.; Klawitter, J.; Brunner, N.; Schmitz, V.; Shokati, T.; Lawrence, R.; Arbelaez, M.F.; Schniedewind, B.; Christians, U.; Klawitter, J. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat. PLoS One, 2012, 7(10)e48063
[http://dx.doi.org/10.1371/journal.pone.0048063] [PMID: 23118926]
[29]
Prado e Silva, M.; Soto, S.F.; Almeida, F.M.; Limonete, T.T.K.; Parra, E.R.C.; Jatene, F.B.; Pêgo-Fernandes, P.M.; Pazetti, R. Immunosuppression effects on airway mucociliary clearance: comparison between two triple therapies. Ann. Thorac. Surg., 2013, 96(2), 473-477.
[http://dx.doi.org/10.1016/j.athoracsur.2013.04.069] [PMID: 23806228]
[30]
Corá, L.A.; Romeiro, F.G.; Américo, M.F.; Oliveira, R.B.; Baffa, O.; Stelzer, M.; Miranda, J.R.A. Gastrointestinal transit and disintegration of enteric coated magnetic tablets assessed by ac biosusceptometry. Eur. J. Pharm. Sci., 2006, 27(1), 1-8.
[http://dx.doi.org/10.1016/j.ejps.2005.08.009] [PMID: 16188432]
[31]
Miranda, J.R.A.; Baffa, O.; de Oliveira, R.B.; Matsuda, N.M. An AC biosusceptometer to study gastric emptying. Med. Phys., 1992, 19(2), 445-448.
[http://dx.doi.org/10.1118/1.596832] [PMID: 1584144]
[32]
Corá, L.A.; Américo, M.F.; Romeiro, F.G.; Oliveira, R.B.; Miranda, J.R.A. Pharmaceutical applications of AC biosusceptometry. Eur. J. Pharm. Biopharm., 2010, 74(1), 67-77.
[http://dx.doi.org/10.1016/j.ejpb.2009.05.011] [PMID: 19482083]
[33]
Yin, J.; Chen, J.D.Z. Electrogastrography: Methodology, validation and applications. J. Neurogastroenterol. Motil., 2013, 19(1), 5-17.
[http://dx.doi.org/10.5056/jnm.2013.19.1.5] [PMID: 23350042]
[34]
Frei, E.H.; Gunders, E.; Pajewsky, M.; Alkan, W.J.; Eshchar, J. Ferrites as contrast material for medical x‐ray diagnosis. J. Appl. Phys., 1968, 39, 999-1001.
[http://dx.doi.org/10.1063/1.1656366]
[35]
Podczeck, F.; Newton, J.M.; Yuen, K.H. The description of the gastrointestinal transit of pellets assessed by gamma scintigraphy using statistical moments. Pharm. Res., 1995, 12(3), 376-379.
[http://dx.doi.org/10.1023/A:1016200501563] [PMID: 7617524]
[36]
Lu, C.L.; Chen, C.Y.; Luo, J.C.; Chang, F.Y.; Lee, S.D.; Wu, H.C.; Chen, J.D.Z. Impaired gastric myoelectricity in patients with chronic pancreatitis: role of maldigestion. World J. Gastroenterol., 2005, 11(3), 372-376.
[http://dx.doi.org/10.3748/wjg.v11.i3.372] [PMID: 15637747]
[37]
de Lima, M.B.; Gama, L.A.; Hauschildt, A.T.; Dall’Agnol, D.J.R.; Corá, L.A.; Américo, M.F. Gastrointestinal Motility, Mucosal Mast Cell, and Intestinal Histology in Rats: Effect of Prednisone. BioMed Res. Int., 2017, 20174637621
[PMID: 29057260]
[38]
de Oliveira Belém, M.; Cirilo, C.P.; de Santi-Rampazzo, A.P.; Schoffen, J.P.F.; Comar, J.F.; Natali, M.R.M.; de Almeida Araújo, E.J. Intestinal morphology adjustments caused by dietary restriction improves the nutritional status during the aging process of rats. Exp. Gerontol., 2015, 69, 85-93.
[http://dx.doi.org/10.1016/j.exger.2015.05.002] [PMID: 25959567]
[39]
Depoortere, I.; De Winter, B.; Thijs, T.; De Man, J.; Pelckmans, P.; Peeters, T. Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro. Eur. J. Pharmacol., 2005, 515(1-3), 160-168.
[http://dx.doi.org/10.1016/j.ejphar.2005.04.008] [PMID: 15890336]
[40]
Takahashi, T. Mechanism of interdigestive migrating motor complex. J. Neurogastroenterol. Motil., 2012, 18(3), 246-257.
[http://dx.doi.org/10.5056/jnm.2012.18.3.246] [PMID: 22837872]
[41]
Bielefeldt, K.; Sharma, R.V.; Whiteis, C.; Yedidag, E.; Abboud, F.M. Tacrolimus (FK506) modulates calcium release and contractility of intestinal smooth muscle. Cell Calcium, 1997, 22(6), 507-514.
[http://dx.doi.org/10.1016/S0143-4160(97)90078-6] [PMID: 9502200]
[42]
Wouters, M.M.; Vicario, M.; Santos, J. The role of mast cells in functional GI disorders. Gut, 2016, 65(1), 155-168.
[http://dx.doi.org/10.1136/gutjnl-2015-309151] [PMID: 26194403]
[43]
Maes, B.D.; Vanwalleghem, J.; Kuypers, D.; Ghoos, Y.; Rutgeerts, P.J.; Vanrenterghem, Y.F. Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. Transplantation, 1999, 68(10), 1482-1485.
[http://dx.doi.org/10.1097/00007890-199911270-00009] [PMID: 10589943]
[44]
Ozkaya, O.; Derici, U.; Buyan, N.; Dalgic, A.; Dalgic, B.; Cingi, E.; Kitapci, M.; Sindel, S.; Hasanoglu, E. Gastric emptying time in renal transplant recipients treated with cyclosporine. Transplant. Proc., 2003, 35(8), 2927-2930.
[http://dx.doi.org/10.1016/j.transproceed.2003.10.063] [PMID: 14697940]
[45]
Eagle, D.A.; Gian, V.; Lauwers, G.Y.; Manivel, J.C.; Moreb, J.S.; Mastin, S.; Wingard, J.R. Gastroparesis following bone marrow transplantation. Bone Marrow Transplant., 2001, 28(1), 59-62.
[http://dx.doi.org/10.1038/sj.bmt.1703084] [PMID: 11498745]
[46]
Camilleri, M.; Parkman, H.P.; Shafi, M.A.; Abell, T.L.; Gerson, L. Clinical guideline: management of gastroparesis. Am. J. Gastroenterol., 2013, 108(1), 18-37.
[http://dx.doi.org/10.1038/ajg.2012.373] [PMID: 23147521]
[47]
Webster, A.C.; Woodroffe, R.C.; Taylor, R.S.; Chapman, J.R.; Craig, J.C. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data. BMJ, 2005, 331(7520), 810.
[http://dx.doi.org/10.1136/bmj.38569.471007.AE] [PMID: 16157605]
[48]
Stevens, J.E.; Jones, K.L.; Rayner, C.K.; Horowitz, M. Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives. Expert Opin. Pharmacother., 2013, 14(9), 1171-1186.
[http://dx.doi.org/10.1517/14656566.2013.795948] [PMID: 23663133]
[49]
Arora, S.; Ali, J.; Ahuja, A.; Khar, R.K.; Baboota, S. Floating drug delivery systems: a review. AAPS PharmSciTech, 2005, 6(3), E372-E390.
[http://dx.doi.org/10.1208/pt060347] [PMID: 16353995]
[50]
Bertoni, S.; Ballabeni, V.; Flammini, L.; Gobbetti, T.; Impicciatore, M.; Barocelli, E. Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles. Neurogastroenterol. Motil., 2008, 20(11), 1234-1242.
[http://dx.doi.org/10.1111/j.1365-2982.2008.01174.x] [PMID: 18684211]
[51]
Kumral, D.; Zfass, A.M. Gut Movements: A review of the physiology of gastrointestinal transit. Dig. Dis. Sci., 2018, 63(10), 2500-2506.
[http://dx.doi.org/10.1007/s10620-018-5259-1] [PMID: 30145693]
[52]
Andreis, U.; Américo, M.F.; Corá, L.A.; Oliveira, R.B.; Baffa, O.; Miranda, J.R.A. Gastric motility evaluated by electrogastrography and alternating current biosusceptometry in dogs. Physiol. Meas., 2008, 29(9), 1023-1031.
[http://dx.doi.org/10.1088/0967-3334/29/9/002] [PMID: 18698113]
[53]
Böhmer, A.E.; Mendes Ribeiro Corrêa, A.; de Souza, D.G.; Knorr, L.; Hansel, G.; Corbellini, L.G.; Driemeier, D.; Portela, L.V.; Souza, D.O. Long-term cyclosporine treatment: evaluation of serum biochemical parameters and histopathological alterations in Wistar rats. Exp. Toxicol. Pathol., 2011, 63(1-2), 119-123.
[http://dx.doi.org/10.1016/j.etp.2009.10.005] [PMID: 19939655]
[54]
Piao, S.G.; Lim, S.W.; Doh, K.C.; Jin, L.; Heo, S.B.; Zheng, Y.F.; Bae, S.K.; Chung, B.H.; Li, C.; Yang, C.W. Combined treatment of tacrolimus and everolimus increases oxidative stress by pharmacological interactions. Transplantation, 2014, 98(1), 22-28.
[http://dx.doi.org/10.1097/TP.0000000000000146] [PMID: 24825522]
[55]
Caires, A.; Fernandes, G.S.; Leme, A.M.; Castino, B.; Pessoa, E.A.; Fernandes, S.M.; Fonseca, C.D.; Vattimo, M.F.; Schor, N.; Borges, F.T. Endothelin-1 receptor antagonists protect the kidney against the nephrotoxicity induced by cyclosporine-A in normotensive and hypertensive rats. Braz. J. Med. Biol. Res., 2017, 51(2)e6373
[http://dx.doi.org/10.1590/1414-431x20176373] [PMID: 29267497]
[56]
Busauschina, A.; Schnuelle, P.; van der Woude, F.J. Cyclosporine nephrotoxicity. Transplant. Proc., 2004, 36(Suppl. 2), 229S-233S.
[http://dx.doi.org/10.1016/j.transproceed.2004.01.021] [PMID: 15041343]
[57]
Sereno, J.; Parada, B.; Rodrigues-Santos, P.; Lopes, P.C.; Carvalho, E.; Vala, H.; Teixeira-Lemos, E.; Alves, R.; Figueiredo, A.; Mota, A.; Teixeira, F.; Reis, F. Serum and renal tissue markers of nephropathy in rats under immunosuppressive therapy: Cyclosporine versus sirolimus. Transplant. Proc., 2013, 45(3), 1149-1156.
[http://dx.doi.org/10.1016/j.transproceed.2013.02.085] [PMID: 23622648]

Rights & Permissions Print Cite
Article Metrics
13
© 2024 Bentham Science Publishers | Privacy Policy